• AAPL 168
  • TSLA 155.45
  • AMZN 181.28
  • MSFT 411.84
  • INTC 35.68
  • EURUSD 1.068
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. PINK /
  3. CTABF.PINK

Canntab Therapeutics Limited (CTABF PINK) stock market data APIs

$0.0073 0(0%) as of April 17, 2024

Canntab Therapeutics Limited Financial Data Overview

0.0073
0.0073
-
0.0073
0.0073
0.0016-0.0135
284 K
38 909 K
73 476
-0.0079
1.428
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'CTABF',
Type: 'Common Stock',
Name: 'Canntab Therapeutics Limited',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG0072K1N23',
ISIN: NULL,
CUSIP: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'May',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - Specialty & Generic',
HomeCategory: NULL,
IsDelisted: false,
}

Canntab Therapeutics Limited Fundamental Data is available in our Financial Data APIs

  • Net Revenue 73 476
  • EBITDA -3 028 307
  • Earnings Per Share -0.07
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Canntab Therapeutics Limited Earnings via APIs

  • Latest Release 2023-02-28
  • EPS/Forecast NaN

Get Canntab Therapeutics Limited End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Canntab Therapeutics Limited latest news via APIs

Canntab Therapeutics Announces Engagement of Relations Publiques Paradox Inc. for Investor Relations Services

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE U.S. TORONTO, March 28, 2019 (GLOBE NEWSWIRE) -- Canntab Therapeutics Limited (CSE: PILL) (the “Company” or “Cannta...
  • CANADA
  • CANADIAN STOCK EXCHANGE:PILL.CN
  • CANNABIS
  • CANNTAB
  • CANNTAB THERAPEUTICS LIMITED
  • HEMP
  • INVESTOR RELATIONS
  • JEAN-FRANCOIS
  • MEILLEUR
  • PARADOX
  • PUBLIQUES

Canntab Enters into Five Year Supply and Loan Agreement with FSD Pharma and World Class Extractions on Organic Hemp Deal

TORONTO, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Canntab Therapeutics Limited (CSE: PILL, OTCQB: CTABF, FSE: TBF1) (“Canntab” or the “Company”) is pleased to announce that it has entered into a su...
  • CANADA
  • CANADIAN STOCK EXCHANGE:PILL.CN
  • CANNABIS
  • CANNTAB
  • CANNTAB THERAPEUTICS LIMITED
  • FSD
  • FSD PHARMA
  • HEMP
  • SUPPLY AGREEMENT
  • WORLD CLASS
  • WORLD CLASS EXTRACTIONS
Do you have any questions?
support@eodhistoricaldata.com